AR058923A1 - Soluciones esterilizadas para dialisis peritoneal que contienen heparina - Google Patents

Soluciones esterilizadas para dialisis peritoneal que contienen heparina

Info

Publication number
AR058923A1
AR058923A1 ARP070100045A ARP070100045A AR058923A1 AR 058923 A1 AR058923 A1 AR 058923A1 AR P070100045 A ARP070100045 A AR P070100045A AR P070100045 A ARP070100045 A AR P070100045A AR 058923 A1 AR058923 A1 AR 058923A1
Authority
AR
Argentina
Prior art keywords
solutions
peritoneal dialysis
combinations
group
solution
Prior art date
Application number
ARP070100045A
Other languages
English (en)
Spanish (es)
Original Assignee
Baxter C Edward Jr
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter C Edward Jr, Baxter Healthcare Sa filed Critical Baxter C Edward Jr
Publication of AR058923A1 publication Critical patent/AR058923A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP070100045A 2006-01-05 2007-01-04 Soluciones esterilizadas para dialisis peritoneal que contienen heparina AR058923A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/326,236 US20070155672A1 (en) 2006-01-05 2006-01-05 Sterilized peritoneal dialysis solutions containing heparin

Publications (1)

Publication Number Publication Date
AR058923A1 true AR058923A1 (es) 2008-03-05

Family

ID=38225289

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100045A AR058923A1 (es) 2006-01-05 2007-01-04 Soluciones esterilizadas para dialisis peritoneal que contienen heparina

Country Status (8)

Country Link
US (1) US20070155672A1 (https=)
EP (1) EP1988908A2 (https=)
JP (1) JP2009522054A (https=)
CN (1) CN101394855A (https=)
AR (1) AR058923A1 (https=)
MX (1) MX2008008701A (https=)
TW (1) TW200800237A (https=)
WO (1) WO2007079338A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090286740A1 (en) * 2008-05-15 2009-11-19 Fibrex Medical Research & Development Gmbh Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
BR112017014467A2 (pt) * 2015-01-30 2018-01-16 Fresenius Kabi Deutschland Gmbh uso de uma mistura de polímeros modificados de glicose para reduzir a metástase tumoral
CN110269867B (zh) * 2018-03-14 2022-06-21 必康生技(香港)有限公司 用于生物流体净化的组合物
CN114504953B (zh) * 2022-03-14 2023-06-16 上海翊科聚合物科技有限公司 一种中空纤维血液透析膜的制备方法
CN118436679B (zh) * 2024-05-07 2024-09-17 南京汉科明德医疗科技有限公司 一种高稳定性的艾考糊精透析液及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3030272A (en) * 1960-05-26 1962-04-17 Abbott Lab Stable heaparin solution
DE69320078T2 (de) * 1992-02-04 1999-03-25 Baxter International Inc., Deerfield, Ill. 60015 Peritonealdialyselösungen die mindestens ein Dipeptid enthalten
SE9900043D0 (sv) * 1999-01-11 1999-01-11 Astra Ab New use
IT1274351B (it) * 1994-10-06 1997-07-17 Alfa Wassermann Spa Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
CA2155910C (en) * 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
JP4882054B2 (ja) * 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
US20060046975A1 (en) * 2002-12-10 2006-03-02 Ola Carlsson Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
US7141544B2 (en) * 2003-10-10 2006-11-28 Baxter International, Inc. Stabilization of pharmaceutical protein formulations with small peptides

Also Published As

Publication number Publication date
US20070155672A1 (en) 2007-07-05
JP2009522054A (ja) 2009-06-11
CN101394855A (zh) 2009-03-25
MX2008008701A (es) 2009-03-04
TW200800237A (en) 2008-01-01
WO2007079338A2 (en) 2007-07-12
WO2007079338A3 (en) 2008-11-27
EP1988908A2 (en) 2008-11-12

Similar Documents

Publication Publication Date Title
Zhao et al. A novel smart injectable hydrogel prepared by microbial transglutaminase and human-like collagen: Its characterization and biocompatibility
Vivcharenko et al. Elastic and biodegradable chitosan/agarose film revealing slightly acidic pH for potential applications in regenerative medicine as artificial skin graft
CN105339017B (zh) 种植体的表面处理方法
Hu et al. Synergistic effect of carbodiimide and dehydrothermal crosslinking on acellular dermal matrix
US20170215409A1 (en) Lamellar cornea preservation solution
AR049298A1 (es) Soluciones para dialisis peritoneal a base de bicarbonato,metodo de preparacion y recipiente de multiples camaras
JP2015529268A5 (https=)
ES2364122T3 (es) Composiciones oftálmicas que comprenden un fructano modificado con carboxilo o una sal del mismo.
BRPI1006231A2 (pt) ''complexo composto por ma insulina e um polissacarídeo contendo grupos carboxila funcionais, composição farmacêutica e uso do complexo''
ATE452659T1 (de) Verfahren zur sterilisation verpackter kontaktlinsen mit verpackungslösung
CN104958791A (zh) 一种青光眼外科手术用复合生物基质及其制备方法
JP2007105265A (ja) 生物由来スキャフォールドの作製方法
CN108578772B (zh) 一种用于提升生物相容性的血液接触材料制备方法及血液接触材料
CN102526803B (zh) 一种仿生基质型生物愈创材料的制备方法
MX2010006650A (es) Materiales y metodos para el tratamiento de proliferacion vascular ocular patologica.
CN105056284A (zh) 一种多壁碳纳米管/壳聚糖/氧化再生纤维素复合止血材料的制备方法
CN102119932A (zh) 硅酮水凝胶隐形眼镜用眼科组合物
CN103638562A (zh) 软骨组织工程支架材料及其制备方法
JP2016534118A (ja) 動物組織材料の消毒・滅菌方法及び動物組織浸漬溶液
Halim et al. Biocompatibility and biodegradation of chitosan and derivatives
AR058923A1 (es) Soluciones esterilizadas para dialisis peritoneal que contienen heparina
CN102470115B (zh) 硅酮水凝胶隐形眼镜用眼科组合物
CN102671242A (zh) 一种脱细胞心包材料的制备方法
CN101766842B (zh) 人工器官用生物组织材料及其制备方法
CN105536058A (zh) 一种医用淀粉海绵及其制备方法和用途

Legal Events

Date Code Title Description
FA Abandonment or withdrawal